I'm looking at CYP with a view to investing. I have a question which concerns me a bit. Their lead product is about to enter Phase 2 for GvHD but I notice that Mesoblast has a product filing for FDA approval for treating the same illness. Does CYP have a better product ? Will CYP be preferred on cost due to their manufacturing process ? Interested to hear the views from existing investors in CYP.
2020 - A Year Full Of Potentials, page-213
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.5¢ | $2.23K | 10.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1339 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 135000 | 2 |
View Market Depth
| Last trade - 13.49pm 26/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |